144 related articles for article (PubMed ID: 15642226)
1. Preparation of arsenic trioxide-loaded albuminutes immuno-nanospheres and its specific killing effect on bladder cancer cell in vitro.
Zhou J; Zeng FQ; Li C; Tong QS; Gao X; Xie SS; Yu LZ
Chin Med J (Engl); 2005 Jan; 118(1):50-5. PubMed ID: 15642226
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis inducing effects of arsenic trioxide on human bladder cancer cell line BIU-87.
Tong Q; Zeng F; Zheng L; Zhao J; Lu G
Chin Med J (Engl); 2001 Apr; 114(4):402-6. PubMed ID: 11780464
[TBL] [Abstract][Full Text] [Related]
3. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
Wang X; Wang G; Dong D; Fu S; Yang B
Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide (As2O3) sensitivity of carcinoma cell lines and cancer cells from patients with carcinomatosis peritonei.
Moon Y; Park G; Kim Y; Kim M; Lim J; Pai SH; Lee EJ; Kang CS; Han K
Ann Clin Lab Sci; 2004; 34(3):271-6. PubMed ID: 15487701
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor effect of nanospheres coupled with the anti-human liver cancer monoclonal antibody HAb18].
Kan HP; Liu ZJ; Tan YF; Lin YX; Li CF; Zhou J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1503-5. PubMed ID: 18753092
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral injection of arsenic to enhance antitumor efficacy in human esophageal carcinoma cell xenografts.
Shen ZY; Zhang Y; Chen JY; Chen MH; Shen J; Luo WH; Zeng Y
Oncol Rep; 2004 Jan; 11(1):155-9. PubMed ID: 14654919
[TBL] [Abstract][Full Text] [Related]
7. Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells.
Chen C; Zhang Y; Wang Y; Huang D; Xi Y; Qi Y
Anticancer Drugs; 2011 Jun; 22(5):435-43. PubMed ID: 21502917
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.
Zhou C; Boggess JF; Bae-Jump V; Gehrig PA
Gynecol Oncol; 2007 Apr; 105(1):218-22. PubMed ID: 17275888
[TBL] [Abstract][Full Text] [Related]
9. Construction of a BALB/c-Nu Mouse Model of Invasive Bladder Carcinoma and Preliminary Studies on the Treatment of Bladder Tumors through Internal Iliac Arterial Infusion of Albumin-Bound Arsenic Trioxide (As2O3).
Li Y; Yu G; Li Q; Wang W; Shen X; Liu H; Liu R
PLoS One; 2015; 10(4):e0124959. PubMed ID: 25915411
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of growth and angiogenesis in heterotransplanted esophageal carcinoma via intratumoral injection of arsenic trioxide.
Shen ZY; Shen J; Chen MH; Wu XY; Wu MH; Zeng Y
Oncol Rep; 2003; 10(6):1869-74. PubMed ID: 14534710
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
[TBL] [Abstract][Full Text] [Related]
12. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia.
Sahu GR; Jena RK
Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419
[TBL] [Abstract][Full Text] [Related]
13. Morphological and biochemical changes induced by arsenic trioxide in neuroblastoma cell lines.
Ryu KH; Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Kie JH; Shin HY; Ahn HS
Pediatr Hematol Oncol; 2005; 22(7):609-21. PubMed ID: 16166054
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide in environmentally and clinically relevant concentrations interacts with calcium homeostasis and induces cell type specific cell death in tumor and non-tumor cells.
Florea AM; Büsselberg D
Toxicol Lett; 2008 Jun; 179(1):34-42. PubMed ID: 18485628
[TBL] [Abstract][Full Text] [Related]
15. Effects of arsenic trioxide under different administration ways on T-cell lymphoma xenografts in nude mice: in vivo and in vitro experiments.
Gao Y; Cai QQ; Li S; Bu Q; Liao H; Zhou Y; Huang HQ
Ai Zheng; 2009 Feb; 28(2):127-31. PubMed ID: 19550119
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of nuclear matrix proteins during arsenic trioxide induced apoptosis in leukemia K562 cells.
Wang ZH; Yu D; Chen Y; Hao JZ
Chin Med J (Engl); 2005 Jan; 118(2):100-4. PubMed ID: 15667793
[TBL] [Abstract][Full Text] [Related]
17. [Study on the specific killing activity of albumin nanoparticles containing adriamycin targeted by monoclonal antibody BDI-1 to human bladder cancer cells].
Sheng J; Samten BK; Xie SS; Wei SL
Yao Xue Xue Bao; 1995; 30(9):706-10. PubMed ID: 8701747
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo.
Yu J; Qian H; Li Y; Wang Y; Zhang X; Liang X; Fu M; Lin C
Gynecol Oncol; 2007 Aug; 106(2):400-6. PubMed ID: 17512576
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
Wang Y; An R; Dong X; Pan S; Duan G; Sun X
Urol Int; 2009; 82(2):214-21. PubMed ID: 19322013
[TBL] [Abstract][Full Text] [Related]
20. Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells.
Chan JY; Siu KP; Fung KP
Cancer Lett; 2006 May; 236(2):250-8. PubMed ID: 15982806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
